{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-114228","form_type":"8-K","ticker":"KMTS","cik":"0001877184","company_name":"KESTRA MEDICAL TECHNOLOGIES, LTD.","filed_at":"2025-09-11T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.481647+00:00","generated_at":"2026-05-17T06:54:25.159082+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Kestra Medical Q1 FY26 revenue up 52% to $19.4M; raises FY26 guidance to $88M","bullets":["Revenue $19.4M (+52% YoY); gross margin expanded to 45.7% from 32.9%.","GAAP net loss $25.8M vs $20.3M; adjusted EBITDA loss $19.4M vs $15.7M.","4,205 prescriptions for ASSURE system, up 51% YoY; driven by new accounts and in-network mix.","FY26 revenue guidance raised to $88M, representing 47% growth over FY25.","Cash and equivalents $201.2M as of July 31, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-114228","json":"https://secwatch.observer/filing/0000950170-25-114228.json","markdown":"https://secwatch.observer/filing/0000950170-25-114228.md","text":"https://secwatch.observer/filing/0000950170-25-114228.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1877184/000095017025114228/0000950170-25-114228-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1877184/000095017025114228/ck0001877184-20250911.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T06:54:25.159082+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}